Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2023-02-21 2023-02-20
Drug Identification Number 02230593 02230593
Brand name NEOSTIGMINE OMEGA NEOSTIGMINE OMEGA
Common or Proper name Neostigmine Methylsulfate Injection USP Neostigmine Methylsulfate Injection USP
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients NEOSTIGMINE METHYLSULFATE NEOSTIGMINE METHYLSULFATE
Strength(s) 0.5MG 0.5MG
Dosage form(s) LIQUID LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1mL vial / fiole 10 x 1mL vial / fiole
ATC code N07AA N07AA
ATC description PARASYMPATHOMIMETICS PARASYMPATHOMIMETICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2023-02-20 2023-02-20
Remaining supply date 2021-11-29 2021-11-29
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments